ВРТ1. Название Стр
 Скачать 1.93 Mb.
|
|
Fertil Steril [Internet]. 2015;104(5):1145. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26297646 270. Fan W, Li S, Chen Q, Huang Z, Ma Q, Wang Y. Recombinant Luteinizing Hormone supplementation in poor responders undergoing IVF: a systematic review and meta-analysis. Gynecol Endocrinol [Internet]. 2013;29(4):278–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23347045 271. Lehert P, Kolibianakis EM, Venetis CA, Schertz J, Saunders H, Arriagada P, et al. Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. Reprod Biol Endocrinol [Internet]. 2014;12:17. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24555766 272. Youssef MA, van Wely M, Al-Inany H, Madani T, Jahangiri N, Khodabakhshi S, et al. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial. Hum Reprod. 2017;32(1):112–8. 273. Ragni G, Levi-Setti PE, Fadini R, Brigante C, Scarduelli C, Alagna F, et al. Clomiphene citrate versus high doses of gonadotropins for in vitro fertilisation in women with compromised ovarian reserve: a randomised controlled non-inferiority trial. Reprod Biol Endocrinol [Internet]. 2012;10:114. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23249758 274. Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org. Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline. Fertil Steril [Internet]. 2018;109(6):993–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29935660 275. Polyzos NP, Blockeel C, Verpoest W, De Vos M, Stoop D, Vloeberghs V, et al. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria. Hum Reprod. 2012;27(12):3481–6. 276. Reynolds KA, Omurtag KR, Jimenez PT, Rhee JS, Tuuli MG, Jungheim ES. Cycle cancellation and pregnancy after luteal estradiol priming in women defined as poor responders: a systematic review and meta-analysis. Hum Reprod [Internet]. 2013;28(11):2981–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23887073 277. Vaiarelli A, Cimadomo D, Trabucco E, Vallefuoco R, Buffo L, Dusi L, et al. Double Stimulation in the Same Ovarian Cycle (DuoStim) to Maximize the Number of Oocytes Retrieved From Poor Prognosis Patients: A Multicenter Experience and SWOT Analysis. Front Endocrinol (Lausanne) [Internet]. 2018;9:317. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29963011 278. Humaidan P, Alviggi C, Fischer R, Esteves SC. The novel POSEIDON stratification of “Low prognosis patients in Assisted Reproductive Technology” and its proposed marker of successful outcome. F1000Research [Internet]. 2016;5:2911. Available from: 164 http://www.ncbi.nlm.nih.gov/pubmed/28232864 279. Poseidon Group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number), Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril [Internet]. 2016;105(6):1452–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26921622 280. Cobo A, Garrido N, Crespo J, José R, Pellicer A. Accumulation of oocytes: a new strategy for managing low-responder patients. Reprod Biomed Online [Internet]. 2012;24(4):424–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22386762 281. Forman EJ, Hong KH, Ferry KM, Tao X, Taylor D, Levy B, et al. In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial. Fertil Steril. 2013 Jul;100(1):100–7.e1. 282. Galliano D, Bellver J, Díaz-García C, Simón C, Pellicer A. ART and uterine pathology: how relevant is the maternal side for implantation? Hum Reprod Update [Internet]. 21(1):13–38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25155826 283. Kremer C, Duffy S, Moroney M. Patient satisfaction with outpatient hysteroscopy versus day case hysteroscopy: randomised controlled trial. BMJ [Internet]. 2000;320(7230):279–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10650023 284. Guida M, Pellicano M, Zullo F, Acunzo G, Lavitola G, Palomba S, et al. Outpatient operative hysteroscopy with bipolar electrode: a prospective multicentre randomized study between local anaesthesia and conscious sedation. Hum Reprod [Internet]. 2003;18(4):840–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12660281 285. Pellicano M, Guida M, Zullo F, Lavitola G, Cirillo D, Nappi C. Carbon dioxide versus normal saline as a uterine distension medium for diagnostic vaginoscopic hysteroscopy in infertile patients: a prospective, randomized, multicenter study. Fertil Steril [Internet]. 2003;79(2):418–21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12568856 286. AAGL Practice Report: Practice Guidelines for the Diagnosis and Management of Submucous Leiomyomas. J Minim Invasive Gynecol [Internet]. 2012;19(2):152–71. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1553465011011897 287. Marret H, Fritel X, Ouldamer L, Bendifallah S, Brun J-L, De Jesus I, et al. Therapeutic management of uterine fibroid tumors: updated French guidelines. Eur J Obstet Gynecol Reprod Biol [Internet]. 2012;165(2):156–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22939241 288. Klatsky PC, Tran ND, Caughey AB, Fujimoto VY. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol [Internet]. 2008;198(4):357–66. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18395031 289. Коган ИЮ, Беженарь ВФ, Долинский АК, Чмаро МГ. Эффективность вспомогательных методов репродукции у больных с миомой матки. Журнал акушерства и женских болезней. 2012;(4):113–8. 290. Seki H, Takizawa Y, Sodemoto T. Epidural analgesia for painful myomas refractory to medical therapy during pregnancy. Int J Gynaecol Obstet [Internet]. 2003;83(3):303–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14643043 291. Wiesenfeld HC, Hillier SL, Meyn LA, Amortegui AJ, Sweet RL. Subclinical pelvic inflammatory disease and infertility. Obstet Gynecol [Internet]. 2012;120(1):37–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22678036 292. Тапильскя НИ, Карпеев СА, Гайдуков СН. Обоснование эффективности антибактериальной терапии в лечении хронической воспалительной болезни матки. 165 Вестник дерматологии и венерологии. 2015;(2):130–8. 293. Шуршалина, А. В. Клинико-морфологические особенности хронического эндометрита у женщин с нарушением репродуктивной функции: дис. …д-ра мед. наук: 14.01.01 / Шуршалина Анна Владимировна. – М., 2007. – 280 с. 294. Шуршалина АВ. Роль хронического эндометрита в развитии патологии репродуктивной функции. Российский медицинский журнал. 2007;(4):25–7. 295. Cicinelli E, Matteo M, Tinelli R, Lepera A, Alfonso R, Indraccolo U, et al. Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy. Hum Reprod [Internet]. 2015;30(2):323–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25385744 296. Romero R, Espinoza J, Mazor M. Can endometrial infection/inflammation explain implantation failure, spontaneous abortion, and preterm birth after in vitro fertilization? Fertil Steril [Internet]. 2004;82(4):799–804. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15482749 297. Сухих Г, Шуршалина А. Хронический эндометрит. ГЭОТАР-Мед. Москва; 2010. 298. Khastgir G, Abdalla H, Thomas A, Korea L, Latarche L, Studd J. Oocyte donation in Turner’s syndrome: an analysis of the factors affecting the outcome. Hum Reprod [Internet]. 1997;12(2):279–85. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9070711 299. Abir R, Fisch B, Nahum R, Orvieto R, Nitke S, Ben Rafael Z. Turner’s syndrome and fertility: current status and possible putative prospects. Hum Reprod Update [Internet]. 7(6):603–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11727869 300. Hovatta O. Ovarian function and in vitro fertilization (IVF) in Turner syndrome. Pediatr Endocrinol Rev [Internet]. 2012;9 Suppl 2:713–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22946282 301. SWYER GI. Male pseudohermaphroditism: a hitherto undescribed form. Br Med J [Internet]. 1955;2(4941):709–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/13250193 302. Hagman A, Loft A, Wennerholm U-B, Pinborg A, Bergh C, Aittomäki K, et al. Obstetric and neonatal outcome after oocyte donation in 106 women with Turner syndrome: a Nordic cohort study. Hum Reprod [Internet]. 2013;28(6):1598–609. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23539610 303. Practice Committee of American Society For Reproductive Medicine. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil Steril [Internet]. 2012;97(2):282–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22192347 304. Creatsas G, Deligeoroglou E, Tsimaris P, Pantos K, Kreatsa M. Successful pregnancy in a Swyer syndrome patient with preexisting hypertension. Fertil Steril [Internet]. 2011;96(2):e83--5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21782051 305. Morcel K, Camborieux L, Programme de Recherches sur les Aplasies Müllériennes, Guerrier D. Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome. Orphanet J Rare Dis [Internet]. 2007;2:13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17359527 306. MORRIS JM. The syndrome of testicular feminization in male pseudohermaphrodites. Am J Obstet Gynecol [Internet]. 1953;65(6):1192–211. Available from: http://www.ncbi.nlm.nih.gov/pubmed/13057950 307. Committee on Adolescent Health Care. ACOG Committee Opinion No. 728: Müllerian Agenesis: Diagnosis, Management, And Treatment. Obstet Gynecol [Internet]. 2018;131(1):e35--e42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29266078 308. Raziel A, Friedler S, Gidoni Y, Ben Ami I, Strassburger D, Ron-El R. Surrogate in vitro 166 fertilization outcome in typical and atypical forms of Mayer-Rokitansky-Kuster-Hauser syndrome. Hum Reprod [Internet]. 2012;27(1):126–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22052385 309. Wood EG, Batzer FR, Corson SL. Ovarian response to gonadotrophins, optimal method for oocyte retrieval and pregnancy outcome in patients with vaginal agenesis. Hum Reprod [Internet]. 1999;14(5):1178–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10325257 310. Reichman DE, Laufer MR. Mayer-Rokitansky-Küster-Hauser syndrome: fertility counseling and treatment. Fertil Steril [Internet]. 2010;94(5):1941–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20172513 311. Reichman D, Laufer MR, Robinson BK. Pregnancy outcomes in unicornuate uteri: a review. Fertil Steril [Internet]. 2009;91(5):1886–94. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18439594 312. Chan YY, Jayaprakasan K, Tan A, Thornton JG, Coomarasamy A, Raine-Fenning NJ. Reproductive outcomes in women with congenital uterine anomalies: a systematic review. Ultrasound Obstet Gynecol [Internet]. 2011;38(4):371–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21830244 313. Grimbizis GF, Camus M, Tarlatzis BC, Bontis JN, Devroey P. Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update [Internet]. 7(2):161–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11284660 314. Letterie GS. Management of congenital uterine abnormalities. Reprod Biomed Online [Internet]. 2011;23(1):40–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21652266 315. Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine. Uterine septum: a guideline. Fertil Steril [Internet]. 2016;106(3):530–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27235766 316. Venetis CA, Papadopoulos SP, Campo R, Gordts S, Tarlatzis BC, Grimbizis GF. Clinical implications of congenital uterine anomalies: a meta-analysis of comparative studies. Reprod Biomed Online [Internet]. 2014;29(6):665–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25444500 317. Dicker D, Ashkenazi J, Dekel A, Orvieto R, Feldberg D, Yeshaya A, et al. The value of hysteroscopic evaluation in patients with preclinical in-vitro fertilization abortions. Hum Reprod [Internet]. 1996;11(4):730–1. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8671317 318. Lavergne N, Aristizabal J, Zarka V, Erny R, Hedon B. Uterine anomalies and in vitro fertilization: what are the results? Eur J Obstet Gynecol Reprod Biol [Internet]. 1996;68(1– 2):29–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8886677 319. Brucker S, Rall K, Campo R, Oppelt P, Isaacson K. Treatment of Congenital Malformations. Semin Reprod Med. 2011 Mar;29(02):101–12. 320. Revel A. Defective endometrial receptivity. Fertil Steril [Internet]. 2012;97(5):1028–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22542142 321. Pasquier C, Daudin M, Righi L, Berges L, Thauvin L, Berrebi A, et al. Sperm washing and virus nucleic acid detection to reduce HIV and hepatitis C virus transmission in serodiscordant couples wishing to have children. AIDS [Internet]. 2000;14(14):2093–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11061649 322. Semprini AE, Macaluso M, Hollander L, Vucetich A, Duerr A, Mor G, et al. Safe conception 167 for HIV-discordant couples: insemination with processed semen from the HIV-infected partner. Am J Obstet Gynecol [Internet]. 2013;208(5):402.e1--9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23395921 323. Steenvoorden MMC, Cornelissen M, van Leeuwen E, Schuurman NM, Egberink HF, Berkhout B, et al. Integration of immunodeficiency virus in oocytes via intracytoplasmic injection: possible but extremely unlikely. Fertil Steril [Internet]. 2012;98(1):173–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22584022 324. Morgia F, Sbracia M, Schimberni M, Giallonardo A, Piscitelli C, Giannini P, et al. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization. Fertil Steril [Internet]. 2004;81(6):1542–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15193474 325. Janssens RM, Lambalk CB, Schats R, Schoemaker J. Successful in-vitro fertilization in a natural cycle after four previously failed attempts in stimulated cycles: case report. Hum Reprod [Internet]. 1999;14(10):2497–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10527976 326. Pelinck MJ, Hoek A, Simons AHM, Heineman MJ. Efficacy of natural cycle IVF: a review of the literature. Hum Reprod Update [Internet]. 8(2):129–39. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12099628 327. Nargund G, Waterstone J, Bland J, Philips Z, Parsons J, Campbell S. Cumulative conception and live birth rates in natural (unstimulated) IVF cycles. Hum Reprod [Internet]. 2001;16(2):259–62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11157816 328. Lenton EA. Natural cycle IVF with and without terminal HCG: learning from failed cycles. Reprod Biomed Online [Internet]. 2007;15(2):149–55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17697489 329. Kadoch I-J, Phillips SJ, Bissonnette F. Modified natural-cycle in vitro fertilization should be considered as the first approach in young poor responders. Fertil Steril [Internet]. 2011;96(5):1066–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22036050 330. Ho JR, Paulson RJ. Modified natural cycle in in vitro fertilization. Fertil Steril [Internet]. 2017;108(4):572–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28965551 331. Shaulov T, Vélez MP, Buzaglo K, Phillips SJ, Kadoch IJ. Outcomes of 1503 cycles of modified natural cycle in vitro fertilization: a single-institution experience. J Assist Reprod Genet [Internet]. 2015;32(7):1043–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26041679 332. Rongières-Bertrand C, Olivennes F, Righini C, Fanchin R, Taïeb J, Hamamah S, et al. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin- releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation. Hum Reprod [Internet]. 1999;14(3):683–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10221695 333. Allersma T, Farquhar C, Cantineau AEP. Natural cycle in vitro fertilisation (IVF) for subfertile couples. Cochrane database Syst Rev. 2013;(8):CD010550. 334. Kamath MS, Kirubakaran R, Mascarenhas M, Sunkara SK. Perinatal outcomes after stimulated versus natural cycle IVF: a systematic review and meta-analysis. Reprod Biomed Online [Internet]. 2018;36(1):94–101. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29111312 335. Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. In vitro maturation: a committee opinion. Fertil Steril [Internet]. 2013;99(3):663–6. Available from: 168 http://www.ncbi.nlm.nih.gov/pubmed/23391409 336. Shalom-Paz E, Almog B, Shehata F, Huang J, Holzer H, Chian R-C, et al. Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification. Reprod Biomed Online [Internet]. 2010;21(4):566–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20822957 337. Chang EM, Song HS, Lee DR, Lee WS, Yoon TK. In vitro maturation of human oocytes: Its role in infertility treatment and new possibilities. Clin Exp Reprod Med [Internet]. |